This report contains market size and forecasts of C13 Stable Isotope Labeled Biomolecules in global, including the following market information:
Global C13 Stable Isotope Labeled Biomolecules Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global C13 Stable Isotope Labeled Biomolecules Market Sales, 2017-2022, 2023-2028, (MT)
Global top five C13 Stable Isotope Labeled Biomolecules companies in 2021 (%)
The global C13 Stable Isotope Labeled Biomolecules market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Medical C13 Stable Isotope Labeled Biomolecules Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of C13 Stable Isotope Labeled Biomolecules include Cambridge Isotope Laboratories, Sigma-Aldrich, Thermo Fisher Scientific, LGC Standards, Toronto Research Chemicals, IsoLife BV, WITEGA Laboratorien, Omicron Biochemicals and Icon Isotopes and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the C13 Stable Isotope Labeled Biomolecules manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global C13 Stable Isotope Labeled Biomolecules Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global C13 Stable Isotope Labeled Biomolecules Market Segment Percentages, by Type, 2021 (%)
Medical C13 Stable Isotope Labeled Biomolecules
Others
Global C13 Stable Isotope Labeled Biomolecules Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global C13 Stable Isotope Labeled Biomolecules Market Segment Percentages, by Application, 2021 (%)
Scientific Research
Medical
Industrial
Others
Global C13 Stable Isotope Labeled Biomolecules Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (MT)
Global C13 Stable Isotope Labeled Biomolecules Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies C13 Stable Isotope Labeled Biomolecules revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies C13 Stable Isotope Labeled Biomolecules revenues share in global market, 2021 (%)
Key companies C13 Stable Isotope Labeled Biomolecules sales in global market, 2017-2022 (Estimated), (MT)
Key companies C13 Stable Isotope Labeled Biomolecules sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cambridge Isotope Laboratories
Sigma-Aldrich
Thermo Fisher Scientific
LGC Standards
Toronto Research Chemicals
IsoLife BV
WITEGA Laboratorien
Omicron Biochemicals
Icon Isotopes
Medical Isotopes